Columbia University and Pfizer to Establish Clinical Trials Diversity Initiative

Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, with the aim of reducing health disparities by increasing the participation of underrepresented minorities in clinical trials and enhancing the diversity of clinical researchers. Pfizer will provide a three-year, $10 million grant to Columbia to help establish and expand the Initiative. Learn more.